News
Kelley Mack of 'The Walking Dead' passed away at 33 following her battle with glioma. Learn about her diagnosis symptoms and ...
Kelley Mack, an actor who starred in "The Walking Dead," died due to complications from the COVID-19 vaccine. Actor Kelley ...
Kelley Mack’s death on Aug. 2 at age 33 was "very unexpected," her rep tells PEOPLE. The 'Walking Dead' actress was still ...
The FDA has granted accelerated approval to Modeyso (dordaviprone) for the treatment of diffuse midline glioma harboring an ...
Modeyso is the first and only approved treatment for recurrent H3 K27M-mutant diffuse midline glioma in patients aged one ...
The FDA has granted accelerated approval to Modeyso (dordaviprone) for the treatment of certain patients with diffuse midline glioma.
Former "The Walking Dead" and "Chicago Med" actress Kelley Mack died on Saturday, Aug. 2, after revealing she had diffuse ...
Kelley Mack, known for her role in The Walking Dead, sadly passed away at 33 after battling diffuse midline glioma, a rare ...
12h
US Weekly on MSN‘9-1-1’ and ‘Walking Dead’ Star Kelley Mack’s Death Was ‘Total’ Surprise After Cancer TreatmentWalking Dead' actress Kelley Mack's death at 33 came as a surprise after her recovery from treatment for a rare glioma cancer ...
Modeyso is the first drug to treat patients with diffuse midline glioma with an H3 K27M mutation, an ultra-rare and aggressive brain tumor.
15h
GlobalData on MSNFDA gives accelerated approval to Jazz Pharma’s diffuse midline glioma therapyThe US FDA has given accelerated approval to Jazz Pharma for Modeyso to treat adult and paediatric patients with diffuse midline glioma.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results